Back to results
US 11,634,418 B2Granted
Amino acid compounds and methods of use
AssigneePliant Therapeutics, Inc.
InventorsDavid John Morgans, Jr., Randall L. Halcomb, Gustave Bergnes, Hui Li, Lan Jiang, Jacob Cha, Timothy Hom
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of formula (I): or a salt thereof, wherein R1, R5, R7, R8, X, m, n, p and q are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating tissue specific fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
Claims41
A compound of formula (I-A):
- or a salt thereof, wherein:
- R1 is C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, 3- to 12-membered heterocyclyl, —OR2 or —NR3aR3b, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R1 are independently optionally substituted by R10;
- R2 is C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, or 3- to 12-membered heterocyclyl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R2 are independently optionally substituted by R10;
- R3a and R3b are independently hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, or 3- to 12-membered heterocyclyl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R3a and R3b are independently optionally substituted by R10;
- or R3a and R3b are taken together with the nitrogen to which they are attached to form a 4- to 8-membered heterocyclyl optionally substituted by R10;
- n is 1 or 2;
- s is 0, 1 or 2, wherein the sum of n and s is 1, 2 or 3;
- the ring defined by is present or absent;
- m is 0 to 6;
- each R5, where present, is independently C1-C6 alkyl, C3-C6 cycloalkyl, halogen, —CN, —OR5a, —C(O)OR5a, —NR5aC(O)R5b;
- —NR5cR5d, —C(O)NR5cR5d, —SO2R5e, or —SO2NR5cR5d, wherein the C1-C6 alkyl and C3-C6 cycloalkyl are independently optionally substituted by R10;
- each R5a and R5b is independently hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, or 3- to 12-membered heterocyclyl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R5a and R5b are independently optionally substituted by R10;
- each R5c and R5d is independently hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, or 3- to 12-membered heterocyclyl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R5c and R5d are independently optionally substituted by R10;
- or R5c and R5d are taken together with the nitrogen to which they are attached to form a 4- to 8-membered heterocyclyl optionally substituted by R10;
- each R5e is independently C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, or 3- to 12-membered heterocyclyl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, C6-C14 aryl, 5- to 10-membered heteroaryl, and 3- to 12-membered heterocyclyl of R5e are independently optionally substituted by R10;
- X is C1-C3 alkylene optionally substituted by R10, —N(R11)—C1-C3 alkylene optionally substituted by R10, —C1-C3 alkylene-N(R11)— optionally substituted by R10, —C1-C3 alkylene-N(R11)—C1-C3 alkylene- optionally substituted by R10, —O—C1-C3 alkylene optionally substituted by R10, —C1-C3 alkylene-O— optionally substituted by R10, —C1-C3 alkylene-O—C1-C3 alkylene- optionally substituted by R10;
- Y is C(Rya)(Ryb) or N(R11);
- each of Rya and Ryb is independently H, C1-C6 alkyl, C3-C6 cycloalkyl, halogen, —CN, —OR5a, —C(O)OR5a, —NR5aC(O)R5b;
- —NR5cR5d, —C(O)NR5cR5d, —SO2R5e, or —SO2NR5cR5d, wherein the C1-C6 alkyl and C3-C6 cycloalkyl are independently optionally substituted by R10;
- p is 0 to 2;
- q is 0 to 6;
- each R7, where present, is independently C1-C6 alkyl optionally substituted by halogen or —OH, C3-C6 cycloalkyl, halogen, —CN, —NO2, —OR7a, or —NR7bR7c;
- each R7a, R7b and R7c is independently hydrogen or C1-C3 alkyl;
- each R8, where present, is independently C1-C6 alkyl, C3-C6 cycloalkyl, halogen, oxo or —OR8a, wherein the C1-C6 alkyl and C3-C6 cycloalkyl are independently optionally substituted by R10;
- R8a is hydrogen or C1-C6 alkyl;
- each R9 is independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, —CN, —OR11, —SR11, —NR12R13, —NO2, —C═NH(OR11), —C(O)R11, —OC(O)R11, —C(O)OR11, —C(O)NR12R13, —NR11C(O)R12, —NR11C(O)OR12, —NR11C(O)NR12R13, —S(O)R11, —S(O)2R11, —NR11S(O)R12, —NR11S(O)2R12, —S(O)NR12R13, —S(O)2NR12R13, —P(O)(OR12)(OR13), C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, 5- to 10-membered heteroaryl, C6-C14 aryl, wherein each R9 is independently optionally substituted by halogen, oxo, —OR14, —NR14R15, —C(O)R14, —CN, —S(O)R14, —S(O)2R14, —P(O)(OR14)(OR15), C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, 5- to 10-membered heteroaryl, C6-C14 aryl, or C1-C6 alkyl optionally substituted by oxo, —OH or halogen;
- each R10 is independently oxo or R9;
- R11 is independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C14 aryl, 5- to 6-membered heteroaryl or 3- to 6-membered heterocyclyl, wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C14 aryl, 5- to 6-membered heteroaryl and 3- to 6-membered heterocyclyl are independently optionally substituted by halogen, oxo, —CN, —OR16, —NR16R17, —P(O)(OR16)(OR17), or C1-C6 alkyl optionally substituted by halogen, —OH or oxo;
- R12 and R13 are each independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C14 aryl, 5- to 6-membered heteroaryl or 3- to 6-membered heterocyclyl, wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C6-C14 aryl, 5- to 6-membered heteroaryl and 3- to 6-membered heterocyclyl are independently optionally substituted by halogen, oxo, —CN, —OR16, —NR16R17 or C1-C6 alkyl optionally substituted by halogen, —OH or oxo;
- or R12 and R13 are taken together with the atom to which they attached to form a 3- to 6-membered heterocyclyl optionally substituted by halogen, oxo, —OR16, —NR16R17 or C1-C6 alkyl optionally substituted by halogen, oxo or —OH;
- R14 and R15 are each independently hydrogen, C1-C6 alkyl optionally substituted by halogen or oxo, C2-C6 alkenyl optionally substituted by halogen or oxo, or C2-C6 alkynyl optionally substituted by halogen or oxo;
- or R14 and R15 are taken together with the atom to which they are attached to form a 3- to 6-membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen or oxo;
- and
- R16 and R17 are each independently hydrogen, C1-C6 alkyl optionally substituted by halogen or oxo, C2-C6 alkenyl optionally substituted by halogen or oxo, or C2-C6 alkynyl optionally substituted by halogen or oxo;
- or R16 and R17 are taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by oxo or halogen.
32 more elements
Dependencies are inferred from the claim text.